Waters Sells $100M in Senior Notes Offering; Plans Another $100M Offering | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters has sold $100 million worth of 3.75 percent Series A Senior Notes due Feb. 1, 2015, in a private placement with institutional purchasers, the firm said in a filing with the US Securities and Exchange Commission today.

The placement was made yesterday and is the first of two senior notes offerings. In the second, expected to take place on March 1, 2010, Waters intends to sell $100 million worth of 5 percent Series B Senior Notes due Feb. 1, 2020.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.